WallStSmart
ASMB

Assembly Biosciences Inc

NASDAQ: ASMB · HEALTHCARE · BIOTECHNOLOGY

$26.95
+2.35% today

Updated 2026-04-30

Market cap
$442.93M
P/E ratio
P/S ratio
6.13x
EPS (TTM)
$-0.55
Dividend yield
52W range
$11 – $40
Volume
0.1M

Assembly Biosciences Inc (ASMB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+74.6%
Last 4 quarters
Revenue YoY growth
+477.3%
Most recent quarter
EPS YoY growth
+258.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+5.6%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.2%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$2.48+392.9%$32.13$33.75+5.0%
2025-11-10$-0.72+54.1%$31.20$33.13+6.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.85$2.48+392.9%$42.47M+477.3%
2025-09-30$-1.57$-0.72+54.1%$10.79M+57.6%
2025-06-30$-1.61$-1.33+17.4%$9.63M+12.8%
2025-03-31$-1.60$-1.17+26.9%$9.42M+62.8%
2024-12-31$-1.75$-1.57+10.3%$7.36M+2.7%
2024-09-30$-2.02$-1.51+25.2%$6.84M
2024-06-30$-2.23$-2.05+8.1%$8.53M
2024-03-31$-3.23$-1.66+48.6%$5.79M
2023-12-31$-2.88$-2.15+25.3%$7.16M
2023-09-30$-0.23$-0.27-17.4%
2023-06-30$-0.29$-0.32-10.3%
2023-03-31$-0.35$-0.37-5.7%

Frequently asked questions

Has Assembly Biosciences Inc beaten earnings estimates?
Assembly Biosciences Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +74.6% over the last 4 quarters.
How does ASMB stock react to earnings?
ASMB stock has moved an average of +5.6% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Assembly Biosciences Inc's revenue growth rate?
Assembly Biosciences Inc reported year-over-year revenue growth of +477.3% in its most recent quarter, with EPS growing +258.0% year-over-year.